Magnetic Resonance Angiography (MRA) proves indispensable in the routine assessment of patients experiencing stroke syndrome, offering a noninvasive and potent means of imaging both cervical and intracranial vessels. It serves as a valuable tool for detecting and diagnosing vascular anomalies, seamlessly integrating with MRI to analyze cerebral parenchyma during the same examination. Hypro Diagnostics benefits from a range of MRA techniques, including contrast-enhanced and non-contrast studies. The utility, artifacts, and limitations of MRA play a pivotal role in guiding therapeutic decisions, particularly in cases of atherosclerotic stenosis, occlusive diseases, and arterial dissections. For hemorrhagic stroke, the role of dynamic MR angiography is crucial for monitoring and controlling intracranial aneurysms. Furthermore, advanced imaging sequences, especially those involving gadolinium injection, significantly contribute to the detection of cerebral vascular malformations, enhancing noninvasive vascular assessment and shaping the course of initial therapeutic strategies within the realm of Hypro Diagnostics.
Reviews
There are no reviews yet.